In an adult, especially an older adult who needs a sleep aid without next‑day drowsiness, is diphenhydramine (Benadryl) a suitable alternative to low‑dose doxepin?

No, Benadryl (diphenhydramine) is NOT a good alternative to doxepin for sleep in adults, especially older adults

The American Academy of Sleep Medicine explicitly recommends AGAINST using diphenhydramine for insomnia, while recommending FOR the use of low-dose doxepin (3-6 mg) for sleep maintenance insomnia. 1

Guideline-Based Recommendations

Diphenhydramine: Not Recommended

• The 2017 AASM clinical practice guideline makes a WEAK recommendation AGAINST diphenhydramine for treating sleep onset and sleep maintenance insomnia in adults 1
• The evidence shows diphenhydramine provides no clinically significant improvement in sleep latency or total sleep time compared to placebo 1
• The 2009 American Geriatrics Society guidelines state there is no systematic evidence for effectiveness of antihistamines for insomnia, and warn that risks outweigh benefits 2

Doxepin: Recommended

• The AASM suggests clinicians USE doxepin (3 mg and 6 mg doses) as treatment for sleep maintenance insomnia in adults 1
• Doxepin demonstrates clinically significant improvements in wake after sleep onset (WASO), total sleep time (TST), and sleep efficiency (SE) 1
• Benefits outweigh harms with doxepin, showing limited adverse effects at low doses 1

Critical Safety Concerns with Diphenhydramine in Older Adults

Next-Day Impairment

• PET scan studies demonstrate diphenhydramine causes 44.7% brain histamine H₁ receptor occupancy the morning after nighttime dosing, indicating substantial residual sedation 3
• This next-day "hangover effect" persists 12 hours after administration, creating risks for falls and cognitive impairment 3

Anticholinergic Burden

• Older adults are particularly vulnerable to anticholinergic effects including confusion, oversedation, urinary retention, constipation, and blurred vision 2, 4
• The FDA label specifically warns that "sedating drugs may cause confusion and oversedation in the elderly" 4
• Recent expert consensus (2025) recommends diphenhydramine should no longer be widely prescribed due to its problematic therapeutic ratio and public health hazard, particularly in older adults 5

Evidence Quality Comparison

Diphenhydramine Evidence

• Only 2 RCTs with low quality evidence due to imprecision and publication bias 1
• Improvements in sleep latency and total sleep time fell below clinical significance thresholds 1
• No systematic safety data available for chronic use 1

Doxepin Evidence

• Multiple RCTs (4 studies each for 3 mg and 6 mg doses) with low quality evidence but demonstrating consistent efficacy 1
• Clinically significant improvements in WASO (exceeding thresholds at both 3 mg and 6 mg), TST, and sleep efficiency 1
• Safety profile comparable to placebo with only mild increase in somnolence at 6 mg dose 1
• FDA-approved specifically for insomnia at low doses (3-6 mg), distinct from higher antidepressant doses 4

Clinical Algorithm for Sleep Aid Selection in Older Adults

Step 1: Assess for sleep maintenance vs. sleep onset insomnia

• If sleep maintenance (difficulty staying asleep): Consider doxepin 3-6 mg 1
• If sleep onset (difficulty falling asleep): Consider alternatives like ramelteon, zaleplon, or zolpidem 1

Step 2: Screen for contraindications

• Doxepin: Check for glaucoma, urinary retention, MAO inhibitor use 4
• Start at lowest dose (3 mg) in elderly patients 4

Step 3: Avoid diphenhydramine

• Do not use as sleep aid regardless of insomnia type 1
• Particularly avoid in older adults due to anticholinergic burden and next-day impairment 2, 3, 5

Common Pitfalls to Avoid

• Do not assume OTC = safer: Diphenhydramine's OTC availability does not indicate superior safety; guidelines explicitly recommend against its use for insomnia 1
• Do not confuse doxepin doses: Low-dose doxepin (3-6 mg) for insomnia is pharmacologically distinct from higher antidepressant doses (75-300 mg) 1, 4
• Do not ignore next-day effects: Diphenhydramine's 44.7% H₁ receptor occupancy 12 hours post-dose creates real fall and accident risks 3
• Do not use long-term without reassessment: Both medications should be part of comprehensive insomnia management, ideally combined with cognitive-behavioral therapy 2

Bottom Line

Diphenhydramine is explicitly not recommended by sleep medicine guidelines for insomnia treatment, while doxepin at low doses (3-6 mg) has guideline support with demonstrated efficacy for sleep maintenance. 1 The evidence hierarchy clearly favors doxepin, particularly in older adults where diphenhydramine's anticholinergic effects and next-day sedation pose significant safety concerns. 2, 4, 3, 5